ACADIA Pharmaceuticals In... (ACAD)
16.31
-0.30 (-1.81%)
At close: Apr 01, 2025, 3:59 PM
16.65
2.10%
Pre-market: Apr 02, 2025, 04:37 AM EDT
ACADIA Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| Revenue | 957.8M | 726.44M | 517.24M | 484.14M | 441.75M | 339.08M | 223.81M | 124.9M | 17.33M | 61K | 120K | 1.15M | 4.91M | 2.07M | 42.13M | 6.4M | 1.59M | 7.55M | 8.13M | 10.96M | 4.6M | 7.38M | 6.28M | 3.71M | 4.31M |
| Cost of Revenue | 81.84M | 45.73M | 10.17M | 19.14M | 20.55M | 19.6M | 18.33M | 13.06M | 4.41M | 76.37M | 60.6M | 26.72M | 18.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 875.96M | 680.71M | 507.07M | 465M | 421.2M | 319.48M | 205.48M | 111.84M | 12.93M | -76.31M | -60.48M | -25.58M | -13.89M | 2.07M | 42.13M | 6.4M | 1.59M | 7.55M | 8.13M | 10.96M | 4.6M | 7.38M | 6.28M | 3.71M | 4.31M |
| Operating Income | 230.79M | -73.38M | -223.6M | -170.44M | -286.59M | -246.54M | -247.44M | -292.41M | -272.81M | -164.61M | -93.23M | -38.3M | -20.89M | -22.85M | 15.09M | -45.47M | -66.98M | -62.65M | -49.05M | -35.81M | -26.1M | -13.74M | -12.63M | -15.28M | -11.27M |
| Interest Income | 25.46M | 17.23M | 6.61M | 591K | 6.61M | 11.16M | 5.35M | 4.13M | 2.76M | 499K | 755K | 349K | 37K | 87K | 82K | 409K | 2.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | 258.07M | -51.04M | -213.44M | -167.52M | -280.97M | -234.38M | -243.94M | -288.28M | -270.05M | -164.11M | -92.47M | -37.95M | -20.85M | -22.77M | 15.14M | -45.15M | -64.24M | -56.39M | -45.05M | -34.13M | -25.92M | n/a | n/a | n/a | n/a |
| Net Income | 226.45M | -61.29M | -215.97M | -167.87M | -281.58M | -235.26M | -245.19M | -289.4M | -271.39M | -164.44M | -92.47M | -37.95M | -20.85M | -22.77M | 15.14M | -45.15M | -64.24M | -56.39M | -45.05M | -34.14M | -25.92M | -14.09M | -12.87M | -14.41M | -10.19M |
| Selling & General & Admin | 488.43M | 402.47M | 369.09M | 396.03M | 388.66M | 325.64M | 265.76M | 255.06M | 186.46M | 90.8M | 32.75M | 12.72M | 7M | 7.61M | 6.46M | 10.28M | 11.82M | 12.27M | 11.35M | 15.91M | 7.25M | 4.18M | 3.98M | 3.76M | 3M |
| Research & Development | 303.25M | 351.62M | 361.57M | 239.41M | 319.13M | 240.38M | 187.16M | 149.19M | 99.28M | 73.87M | 60.6M | 26.72M | 18.79M | 17.31M | 20.58M | 41.59M | 56.75M | 57.94M | 49.4M | 30.85M | 23.45M | 16.93M | 14.92M | 13.09M | 9.73M |
| Other Expenses | -146.51M | n/a | 3.54M | 2.33M | -997K | 997K | -1.84M | 3.98M | 1.33M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.56M | 7.53M | 2.36M | n/a | n/a | 2.15M | 2.85M |
| Operating Expenses | 645.16M | 754.09M | 730.66M | 635.44M | 707.79M | 566.02M | 452.92M | 404.25M | 285.74M | 164.67M | 93.35M | 39.44M | 25.79M | 24.92M | 27.04M | 51.87M | 68.57M | 70.21M | 57.19M | 46.76M | 30.7M | 21.12M | 18.9M | 18.99M | 15.58M |
| Interest Expense | n/a | n/a | 6.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37K | 86K | 181K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | 9.4M | 5.5M | 41.8M | 51.1M | 38.3M | 39.8M | 15.6M | 1.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 727M | 799.82M | 740.83M | 654.58M | 728.34M | 585.62M | 471.25M | 417.31M | 290.15M | 164.67M | 93.35M | 39.44M | 25.79M | 24.92M | 27.04M | 51.87M | 68.57M | 70.21M | 57.19M | 46.76M | 30.7M | 21.12M | 18.9M | 18.99M | 15.58M |
| Income Tax | 31.62M | 10.25M | 2.53M | 351K | 611K | 876K | 1.26M | 1.12M | 1.34M | 330K | -206K | n/a | -109K | n/a | n/a | n/a | -1.04M | n/a | -3.86M | -200 | -200 | 352.6K | 242.3K | 14.41M | 10.19M |
| Shares Outstanding (Basic) | 165.72M | 163.82M | 161.68M | 160.49M | 157.33M | 147.2M | 126.58M | 122.6M | 115.86M | 100.63M | 97.25M | 85.72M | 54.87M | 52.18M | 38.59M | 37.48M | 37.11M | 35.21M | 27.92M | 22.01M | 10.35M | 1.46M | 1.45M | 1.21M | 1.07M |
| Shares Outstanding (Diluted) | 166.36M | 163.82M | 161.68M | 160.49M | 157.33M | 147.2M | 126.58M | 122.6M | 115.86M | 100.63M | 97.25M | 85.72M | 55.12M | 52.18M | 38.72M | 37.48M | 37.11M | 35.21M | 27.92M | 22.01M | 10.35M | 11.37M | 1.45M | 1.21M | 1.07M |
| EPS (Basic) | 1.37 | -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 | 0.39 | -1.2 | -1.73 | -1.6 | -1.61 | -1.55 | -2.5 | -9.66 | -8.86 | -11.93 | -9.53 |
| EPS (Diluted) | 1.36 | -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 | 0.39 | -1.2 | -1.73 | -1.6 | -1.61 | -1.55 | -2.5 | -1.24 | -8.86 | -11.93 | -9.53 |
| EBITDA | 100.16M | -67.83M | -221.57M | -167.09M | -286.59M | -243.78M | -244.44M | -289.7M | -270.99M | -163.47M | -93.02M | -38.22M | -20.78M | -22.48M | 15.7M | -44.36M | -66.98M | -62.65M | -49.05M | -32.93M | -24.18M | -12.4M | -11.22M | -15.28M | -11.27M |
| EBIT | 84.28M | -73.38M | -223.6M | -170.44M | -286.59M | -246.54M | -247.44M | -292.41M | -272.81M | -164.61M | -93.23M | -38.3M | -20.89M | -22.85M | 15.09M | -45.47M | -66.98M | -62.65M | -49.05M | -35.81M | -26.09M | -13.74M | -12.63M | -15.28M | -11.27M |
| Depreciation & Amortization | 15.88M | 5.55M | 2.03M | 3.34M | 2.93M | 2.77M | 3M | 2.71M | 1.83M | 647K | 206K | 79K | 109K | 285K | 607K | 1.11M | 1.04M | 768K | -146K | 1.03M | 1.31M | 1.34M | 1.4M | n/a | n/a |